TAG:
cap
Choosing a Eulogy for SBCL
By R. Lewis Dark | From the Volume VI No. 9 – June 28, 1999 Issue
What is an appropriate eulogy for SmithKline Beecham Clinical Laboratories (SBCL), soon to be acquired by …
Quest and SBCL Expect Merger Date Of July 2
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
CEO SUMMARY: After months of waiting and planning, executives at Quest Diagnostics Incorporated believe that July 2, 1999 will be the date when their acquisition of SmithKline Beecham Clinical Laboratories becomes official. During the month of July, expect a flurry of activity at Quest Di…
Surprise Merger Changes Cytology Marketplace
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
CEO SUMMARY: Expect the merger of AutoCyte, Inc. and NeoPath, Inc. to inaugurate a new market cycle for automated cytology systems. FDA approval of AutoCyte’s liquid preparation system, called PREP™, sets the stage for intensified marketing battles between the AutoCyte/NeoPath consort…
PennState Geisinger Building “ Distributed Lab ” Around POCT
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
CEO SUMMARY: Here’s an integrated healthcare system that’s pushing its clinical laboratory across traditional barriers between physician’s office and clinical lab. At PennState Geisinger Healthcare, a fast-growing health system located in rural Pennsylvania, point-of-care testing is…
Associated Pathologists Laboratories, Dynacare, Bio-Reference Labs, Quest, AmeriPath
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
ASSOCIATED PATH LABS WINS PATENT FOR DRUGS OF ABUSE TEST IT’S NOT TOO OFTEN that independent commercial laboratories are awarded patents. Las Vegas-based Associated Pathologists Laboratories received a patent for a technique it developed relating to drugs of abuse testing….
“June 28, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
South America continues to catch the eye of many North American health insurers. Aetna International, Inc., the international operating subsidiary for Aetna Inc., disclosed its purchase of a 50% interest in Cruz Blanca Columbia. This is a clinic-based healthcare insu…
Investors Coming Back To Clinical Lab Industry
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
CEO SUMMARY: Wall Street money is beginning to flow back into the commercial laboratory industry. This time the beneficiary is Unilab Corporation of Tarzana, California. New York-based Kelso & Company signed an agreement to buy 93% of Unilab’s shares. The common perception among fin…
Developing Technology Expected To Fuel Boom In Anatomic Pathology
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
CEO SUMMARY: Established demographic trends point to a coming boom in the demand for anatomic pathology services. Greater number s of senior citizens, living longer lives, will raise the number of cancer cases diagnosed annually in the United States. New diagnostic technology will increas…
DIANON Systems Nails Contract To Provide AP Services To Aetna
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
Sand sales efforts paid off for DIANON Systems, Inc. of Stratford, Connecticut. Last month the publicly-traded lab disclosed a new contract with Aetna/U.S. Healthcare. The pact, signed with Aetna and SmithKline Beecham Clinical Laboratories (SBCL), …
“June 7, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
Another laboratorian has caught entrepreneur’s fever. Paul Gotcher accepted a position in April as Vice President of Sales and Marketing for Advanced Pathology Systems, Inc. (PSI) of San Francisco. PSI is a start-up company developing enhanced microscopy techniques. Gotcher was mos…
CURRENT ISSUE

Volume XXXII, No. 10 – July 14, 2025
This issue is strong on different flavors of enforcement that clinical laboratories, whether they want to or not, will need to contend with. Lab stakeholders provide insights that medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Also, this issue provides the legal and regulatory landscape for clinical labs’ use of AI and how it evolves with the technology. AI is creating legal uncertainty for clinical labs, especially around data privacy and FDA oversight of AI tools in diagnostics.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized